“Comparison of Adverse Events Between Selective Internal Radiation Therapy Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma in Mongolia: A Subgroup Analysis of SIRveNIB Study”, Cent Asian J Med Sci, vol. 3, no. 3, pp. 297–305, Nov. 2017, doi: 10.24079/cajms.2017.11.011.